Status:
TERMINATED
Machine Learning Neurofeedback for PTSD
Lead Sponsor:
VA Office of Research and Development
Collaborating Sponsors:
Baylor College of Medicine
Conditions:
Post-traumatic Stress Disorder
Eligibility:
All Genders
18-64 years
Phase:
NA
Brief Summary
A commonly used therapy for post-traumatic stress disorder (PTSD) that often (but not always) gives good results is "exposure therapy": When the patient (for example, Veterans who have attacks of anxi...
Detailed Description
A Virtual World/Neuro-feedback Real-time Functional MRI Approach to PTSD Treatment Despite availability of treatment, posttraumatic stress disorder (PTSD) remains a major problem in Veterans, with tr...
Eligibility Criteria
Inclusion
- Meet CAPS5 PTSD criteria
- OEF/OIF/OND \& PGW Veterans
- Seeking treatment for PTSD
Exclusion
- DSM-5 criteria for drug or alcohol abuse or dependence in past 30 days
- History of moderate to severe traumatic brain injury
- Presence of contraindications to MRI
- Current neurological or general medical conditions known to impact cognitive and/or emotional functioning (epilepsy, Parkinson's, etc.)
- Acute psychological instability, schizophrenia, etc.
Key Trial Info
Start Date :
November 1 2018
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
November 24 2020
Estimated Enrollment :
14 Patients enrolled
Trial Details
Trial ID
NCT03482466
Start Date
November 1 2018
End Date
November 24 2020
Last Update
June 28 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Michael E. DeBakey VA Medical Center, Houston, TX
Houston, Texas, United States, 77030